Pennsylvania 2019-2020 Regular Session Status: In Committee Bipartisan · 11 D · 1 R cosponsors

HB 2225 — An Act providing for the study and design of a program for importing prescription drugs.

Last action — PN 3166 Referred to HEALTH

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2019-2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Bill Text

Action History

  1. PN 3166 Referred to HEALTH

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 18 co-sponsors · 234 not signed on

Sponsors (1)

  • Mccarter

Co-sponsors (18)

Not signed on (234)

234 members have not signed on to this bill.

Show all 234 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 2225?
HB 2225 is sponsored by Jeanne McNeill (Democratic), Milou Mackenzie (Republican), Mccarter, Eddie Day Pashinski (Democratic), Michael H. Schlossberg (Democratic), Carol Hill-Evans (Democratic), Robert Freeman (Democratic), Youngblood, Deluca, Kristine C. Howard (Democratic), Robert E. Merski (Democratic), Joe Ciresi (Democratic), Caltagirone, Peter Schweyer (Democratic), Dan Frankel (Democratic), Donatucci, Joanna E. McClinton (Democratic), Mike Zabel, and Stephen Kinsey.
What is the current status of HB 2225?
This bill died with 2019-2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 2225?
Track HB 2225 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2225

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 2225

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →